Skip to main content

Table 2 Spearman correlation coefficient of fasting glucose, hemoglobin A1c (HbA1c) and advanced glycation end products (AGEs) with lipid profiles.

From: Advanced glycation end products (AGEs) in relation to atherosclerotic lipid profiles in middle-aged and elderly diabetic patients

 

DM(N = 207)

DN(N = 174)

 

Males(N = 81)

Females(N = 126)

Males(N = 71)

Females(N = 103)

 

Glucose

HbA1c

AGEs

Glucose

HbA1c

AGEs

Glucose

HbA1c

AGEs

Glucose

HbA1c

AGEs

Age(yrs)

-0.13

-0.15

-0.13

-0.12

-0.10

0.07

-0.40***

-0.10

-0.18

-0.01

0.03

-0.14

Weight(kg)

0.04

0.12

0.33**

0.23**

0.14

0.03

0.13

-0.08

0.27*

-0.07

0.11

0.12

BMI(kg/m2)

0.11

0.18

0.23*

0.18*

0.13

0.08

0.15

-0.09

0.29*

-0.08

0.05

0.11

CHOL(mg/dL)

0.10

0.21

0.12

0.34***

0.34***

0.34***

0.10

0.12

0.35**

0.26**

0.17

0.15

TG(mg/dL)

0.08

0.10

0.77***

0.12

0.24**

0.69***

0.25*

0.32**

0.73***

0.25*

0.26**

0.68***

HDL-C(mg/dL)

-0.02

-0.13

-0.34**

-0.07

0.03

-0.27**

-0.13

-0.17

-0.35**

0.08

0.04

-0.36***

LDL-C(mg/dL)

0.12

0.18

0.12

0.34***

0.35***

0.27**

0.11

0.13

0.19

0.19

0.15

0.03

CHOL/HDL-C

0.10

0.20

0.44***

0.30**

0.21*

0.51***

0.15

0.13

0.48***

0.10

0.09

0.41***

LDL-C/HDL-C

0.05

0.16

0.30*

0.32***

0.27**

0.40***

0.11

0.15

0.28*

0.13

0.14

0.26*

TG/HDL-C

0.11

0.11

0.73***

0.12

0.18

0.65***

0.26*

0.29*

0.72***

0.09

0.14

0.63***

AI

0.18

0.15

0.56***

0.29***

0.33***

0.51***

0.20

0.27*

0.63***

0.24*

0.22*

0.46***

  1. *p < 0.05 **p < 0.01 ***p < 0.001
  2. BMI: body mass index; AGEs: advanced glycation end products; HbA1c: hemoglobin A1c; CHOL: cholesterol; TG: triglyceride; HDL-C: high-density lipoprotein-cholesterol; LDL-C: low density lipoprotein-cholesterol; AI: atherosclerotic index
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X